This episode join us with Dr Oksana Zdanska, hearing about her amazing journey from Czech Rep. to Sydney, working at TKCC + a PhD on the patient experience. We learn about Immvirx, which is developing several viral RNA therapies for cancers of unmet need. open.spotify.com/episode/6BD…
Just wrapped a great few days at AACR D3 in Boston! Thanks to all the presenters for their engaging talks and for everyone's interest in Australian Drug Development and NECTA's work! @AnthonyMJoshua @DrChristinaTeng #NECTA
Excited to share results today in CCR from our very own study demonstrating the power of integrating genomic biomarkers with our clinical trials network for improved patient trial navigation. Huge thanks to @JiaJennyLiu + NECTA investigators leading this!
doi.org/10.1158/1078-0432.CC…
Our latest podcast is now out! Redefining frustration to success, career insights with Neil Fleshner. We hear about his medical career, launching a successful radio-ligand startup company, and advice for others interested in the space! #biofinance #urology open.spotify.com/episode/6Vp…
Looking forward to meeting everyone tomorrow at our annual Drug Development Meeting! Last chance to register and join us for a day exploring the frontiers in clinical development! events.zoom.us/ev/An0is22abE…
Only 1 week left until our annual Drug Development Meeting! We can't wait to see everyone there and welcome our international guest speakers! If you haven't registered yet, don't forget to get a ticket at: events.zoom.us/ev/An0is22abE…
Only a few weeks left until our annual Drug Development Meeting! We can't wait to see everyone there and welcome our international guest speakers! If you haven't registered yet, don't forget to get a ticket at: events.zoom.us/ev/An0is22abE…
Don't forget to register for our Drug Development Meeting 2026! We have a great panel for the day, from global investigators to biotech. Registrations free for academic affiliations and open at the link: events.zoom.us/ev/An0is22abE…
Don't forget to register for our Drug Development Meeting 2026! We have a great panel for the day, from global investigators to biotech. Registrations free for academic affiliations and open at the link: events.zoom.us/ev/An0is22abE…
Registrations are now open for our annual Drug Development Meeting 2026! - Join us for an exciting day meeting with experts in early phase oncology from around the globe!
Registration link below:
events.zoom.us/ev/An0is22abE…
Join us as we bring the year to a close by chatting with about how ctDNA testing can inform better treatment decisions in the clinic. We hear about the power of ctDNA + tumour informed testing and the latest data supporting it's use in GI + other cancers. spotifycreators-web.app.link…
Join us at NECTA and support early phase trials in NSW - we have a great opportunity open for a Regulatory Affairs Officer.
garvan.wd3.myworkdayjobs.com…
NECTA retweeted
Congratulations Associate Professor @AbhijitPal, Medical Oncologist at @SouthWesternSydneyLocalHealthDistrict – winner of the 2025 Improving Equitable Outcomes through Cancer Research Award. #CancerNSWAwards
NECTA retweeted
Congratulations Associate Professor Inês Esteves Domingues Pires da Silva – 2025 Outstanding Mid Career Researcher of the Year. A/Prof Pires da Silva is a distinguished Medical Oncologist and Associate Professor at the @MelanomaAus and @Sydney_Uni. #CancerNSWAwards
We're back after a fascinating talk with Dr Laura Chang at @arteraAI about predictive use of AI in digitalised pathology. Tune in to hear more about how tech is improving prognostic and predictive cancer care outcomes! #AI #cancercare #tech spotifycreators-web.app.link…
NECTA retweeted
While potentially practice changing few of these are immediately actionable in the real world 🌏 due to delays in funding, approval and access.
🗺️ regulatory harmonisation needed to bring 🔬💊 from the podium into everyday practice for our patients who waiting 🩺👩⚕️💕 #ESMO25
~2 wks to #ESMO25! Here’s a📝of🔑studies for GeneralOnc that could change/reinforce SoC:
- #DESTINYBreast 05&11
- #monarchE & #NATALEE
- #VIKTORIA1
- #FORTITUDE01
- #DYNAMIC3
- #STELLAR303
- #KN905
- #IMVigor011
- #PSMAddition
- #MDTBridge
#OncTwitter @myESMO @OncoAlert
NECTA retweeted
Looking forward to #ESMO25, where clinicians will share results from research collaborations with Guardant Health AMEA, and new real-world data across solid tumor types.
A heartfelt thank you to the researchers and collaborators @JiaJennyLiu, @docrohatgi Nir Peled, Amit Rauthan, Shota Fukuoka, @kobashin0117, @Hiroki_Osumi, and Seiichiro Mitani.
We remain committed to collaborating with clinicians to advance real-world evidence in precision oncology.
























